These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 17897631

  • 1. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR, Schober DA, Morin M, Berglund MM.
    Biochem Pharmacol; 2007 Dec 03; 74(11):1652-64. PubMed ID: 17897631
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.
    Holliday ND, Lam CW, Tough IR, Cox HM.
    Mol Pharmacol; 2005 Mar 03; 67(3):655-64. PubMed ID: 15576634
    [Abstract] [Full Text] [Related]

  • 5. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
    Dumont Y, Gaudreau P, Mazzuferi M, Langlois D, Chabot JG, Fournier A, Simonato M, Quirion R.
    Br J Pharmacol; 2005 Dec 03; 146(8):1069-81. PubMed ID: 16231000
    [Abstract] [Full Text] [Related]

  • 6. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors.
    Dautzenberg FM, Neysari S.
    Pharmacology; 2005 Dec 03; 75(1):21-9. PubMed ID: 15908753
    [Abstract] [Full Text] [Related]

  • 7. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z.
    Can J Physiol Pharmacol; 2003 Feb 03; 81(2):177-85. PubMed ID: 12710532
    [Abstract] [Full Text] [Related]

  • 8. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G, Lindberg C, Wörtwein G, Bolwig TG, Woldbye DP.
    J Neurosci Res; 2004 Sep 01; 77(5):723-9. PubMed ID: 15352219
    [Abstract] [Full Text] [Related]

  • 9. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R, Brennauer A, Schneider E, Cabrele C, Beck-Sickinger AG, Bernhardt G, Buschauer A.
    Eur J Pharmacol; 2006 Dec 03; 551(1-3):10-8. PubMed ID: 17027743
    [Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
    Sheriff S, Ali M, Yahya A, Haider KH, Balasubramaniam A, Amlal H.
    Mol Cancer Res; 2010 Apr 03; 8(4):604-14. PubMed ID: 20332211
    [Abstract] [Full Text] [Related]

  • 11. PYY preference is a common characteristic of neuropeptide Y receptors expressed in human, rat, and mouse gastrointestinal epithelia.
    Holliday ND, Pollock EL, Tough IR, Cox HM.
    Can J Physiol Pharmacol; 2000 Feb 03; 78(2):126-33. PubMed ID: 10737675
    [Abstract] [Full Text] [Related]

  • 12. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
    Kanatani A, Mashiko S, Murai N, Sugimoto N, Ito J, Fukuroda T, Fukami T, Morin N, MacNeil DJ, Van der Ploeg LH, Saga Y, Nishimura S, Ihara M.
    Endocrinology; 2000 Mar 03; 141(3):1011-6. PubMed ID: 10698177
    [Abstract] [Full Text] [Related]

  • 13. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM, Saar K, Lundell I, Langel U, Larhammar D.
    Neuropeptides; 2001 Mar 03; 35(3-4):148-53. PubMed ID: 11884204
    [Abstract] [Full Text] [Related]

  • 14. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M, Ghibaudi L, Gao J, Hwa JJ.
    Obes Res; 2005 Jan 03; 13(1):36-47. PubMed ID: 15761161
    [Abstract] [Full Text] [Related]

  • 15. NPY receptor subtype in the rabbit isolated ileum.
    Félétou M, Nicolas JP, Rodriguez M, Beauverger P, Galizzi JP, Boutin JA, Duhault J.
    Br J Pharmacol; 1999 Jun 03; 127(3):795-801. PubMed ID: 10401572
    [Abstract] [Full Text] [Related]

  • 16. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
    Dumont Y, Cadieux A, Doods H, Fournier A, Quirion R.
    Can J Physiol Pharmacol; 2000 Feb 03; 78(2):116-25. PubMed ID: 10737674
    [Abstract] [Full Text] [Related]

  • 17. Expression cloning of a human brain neuropeptide Y Y2 receptor.
    Gehlert DR, Beavers LS, Johnson D, Gackenheimer SL, Schober DA, Gadski RA.
    Mol Pharmacol; 1996 Feb 03; 49(2):224-8. PubMed ID: 8632753
    [Abstract] [Full Text] [Related]

  • 18. Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
    Akerberg H, Fällmar H, Sjödin P, Boukharta L, Gutiérrez-de-Terán H, Lundell I, Mohell N, Larhammar D.
    Regul Pept; 2010 Aug 09; 163(1-3):120-9. PubMed ID: 20471432
    [Abstract] [Full Text] [Related]

  • 19. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
    Tovote P, Meyer M, Beck-Sickinger AG, von Hörsten S, Ove Ogren S, Spiess J, Stiedl O.
    Regul Pept; 2004 Aug 15; 120(1-3):205-14. PubMed ID: 15177939
    [Abstract] [Full Text] [Related]

  • 20. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
    Abounader R, Elhusseiny A, Cohen Z, Olivier A, Stanimirovic D, Quirion R, Hamel E.
    J Cereb Blood Flow Metab; 1999 Feb 15; 19(2):155-63. PubMed ID: 10027771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.